The evidence on infant circumcision

This page is a plain-language, fully referenced review of what the published research actually says about non-therapeutic infant circumcision: the positions of national medical bodies, the real size of the commonly cited benefits, the harms, and the ethical question of consent. It is written to be accurate rather than to score points. Where the evidence is genuinely mixed, it says so, because a case built on overstatement is easy to knock down and a case built on the record is not. Every factual claim below is cited, with links to the source.

What the medical bodies actually say

A common belief is that doctors recommend circumcising infants. They do not. No national medical association in the world recommends routine non-therapeutic infant circumcision. The strongest statement any major body has made is that the benefits are enough to justify access for parents who choose it, not that the procedure should be done.

• United States (AAP). The American Academy of Pediatrics is the body most often quoted in favour. Its 2012 statement said, in its own words, that "health benefits are not great enough to recommend routine circumcision for all male newborns," and left the decision to parents. AAP policy statements automatically expire five years after publication unless renewed. This one was not renewed, so it has been expired since around 2017 and is no longer active policy. A group of 38 physicians from European and Canadian medical societies published a formal rebuttal arguing the AAP had overstated the benefits.
• Canada (CPS). The Canadian Paediatric Society "does not recommend the routine circumcision of every newborn male," and found the balance of benefits and risks "closely balanced."
• Australia and New Zealand (RACP). The Royal Australasian College of Physicians states that the frequency of the relevant diseases, the level of protection offered, and the complication rates "do not warrant routine infant circumcision."
• Netherlands (KNMG). The Royal Dutch Medical Association, backed by seven Dutch medical bodies, concluded there is "no convincing evidence that circumcision is useful or necessary in terms of prevention or hygiene," and that any medical benefit can reasonably wait until the boy is old enough to decide for himself.
• United Kingdom (BMA). The British Medical Association takes a neutral position and has stated that the medical benefits claimed for circumcision "have not been convincingly proven."
• The Nordic countries. In 2013 the children's ombudsmen of Denmark, Finland, Iceland, Norway and Sweden, together with several paediatric associations, issued a joint statement that circumcising boys who cannot consent conflicts with basic medical ethics and with the child's rights.

The World Health Organization does recommend circumcision, but only in a specific context: as one added HIV-prevention measure for adult and adolescent men in the small number of countries with very high HIV rates and low circumcision rates, chiefly in eastern and southern Africa. It has never recommended routine infant circumcision, and its reasoning does not transfer to low-prevalence countries.

For scale: about 37 to 39 percent of the world's men are circumcised, and roughly half of all circumcision is done for religious or cultural reasons rather than medical ones. Routine infant circumcision is uncommon across most of Europe.

How the rest of the developed world sees it

In the countries where routine infant circumcision is rare, the question has largely moved from "is it beneficial" to "is this the child's own body to decide about." Over the past fifteen years national medical associations, ethics councils, children's ombudsmen, and even a pan-European assembly have treated non-therapeutic circumcision of boys as a matter of the child's rights. Few went as far as a ban, and the attempts that reached parliaments mostly did not pass, but the direction is remarkably consistent.

• The Council of Europe. In 2013 its Parliamentary Assembly, in Resolution 1952, said it was "particularly worried about a category of violation of the physical integrity of children," and listed among them "the circumcision of young boys for religious reasons." It asked member states to define proper conditions for the practice rather than to ban it. To be fair, a 2015 follow-up resolution took a softer tone toward religious circumcision, so this is a live debate inside the Council, not a settled European position. But that 2013 language, from the continent's main human-rights assembly, is striking.
• The Nordic children's ombudsmen. In a 2013 joint statement, the children's ombudsmen and child-rights bodies of Norway, Sweden, Finland, Denmark, Iceland and Greenland, together with Nordic paediatric societies, wrote that "there are no health-related reasons for circumcising young boys in the Nordic countries," and that circumcision without a medical indication on a child who cannot consent "violates fundamental medical-ethical principles." Their conclusion: "parents' rights in this context do not prevail over children's right to bodily integrity."
• The Netherlands. The Royal Dutch Medical Association's 2010 position states that non-therapeutic circumcision "conflicts with the child's right to autonomy and physical integrity," and that "there is no convincing evidence that circumcision is useful or necessary in terms of prevention or hygiene."
• Iceland. When a bill to ban non-medical circumcision was introduced in 2018, the Icelandic Medical Association filed in support, writing that circumcision of boys "has no health purpose but may lead to serious complications" and belongs among the unnecessary procedures that should not be performed on children. Roughly 400 to 500 Icelandic doctors signed a declaration backing it. The bill itself did not pass, but the profession's position is on the parliamentary record.
• Denmark. The Danish Medical Association holds that circumcision of a healthy boy "should not be performed before the boy is 18 years old and able to decide" for himself. It stopped short of calling for a legal ban, and a 2021 bill to set an age limit of 18 was voted down, so this is the profession's recommendation, not Danish law.
• Sweden. The Swedish Medical Association's ethics council states plainly that "there are no known medical benefits of the procedure on children," and favours waiting until the person is old enough to consent. Sweden regulates circumcision through a 2001 law, requiring consent, pain relief and a licensed practitioner, rather than banning it.
• Finland. The Finnish Medical Association's ethics guidance holds that because "appropriate consent cannot be obtained from a small boy, circumcision violates the individual's freedom and personal integrity from both an ethical and a legal standpoint." It recommends that doctors discuss declining or postponing the procedure until the boy can decide for himself, and says it should not be paid for with public money.
• Belgium. The federal Advisory Committee on Bioethics concluded in 2017 that society should not pay for non-therapeutic circumcision, and its chair, explaining the decision, said that because the operation is irreversible "the physical integrity of the child takes precedence over the belief system of the parents."
• Germany. After a 2012 court case, the German Ethics Council recommended that circumcision should at a minimum recognise "a development-dependent right of veto of the boy concerned." Germany then passed a law keeping the practice legal with parental consent.

The claimed benefits, in proportion

The benefits people cite are mostly real. The honest question is not whether they exist but how large they are in absolute terms, and whether the same protection can be had in a less drastic way. On both counts the case for cutting a healthy infant is weak.

HIV

Three large randomised trials in Africa (Auvert 2005, Bailey 2007, Gray 2007) found that circumcising adult men reduced female-to-male heterosexual HIV transmission by roughly 50 to 60 percent, and a Cochrane review confirmed the pooled effect. This is the strongest evidence in the whole field. It also comes with heavy limits. The trials were in adult volunteers in a high-prevalence, heterosexual epidemic. The protection has not been shown for men who have sex with men (Millett 2008). Because the benefit is a relative reduction on a high baseline risk, the absolute benefit shrinks dramatically in low-prevalence countries. All three trials were stopped early, which tends to inflate the measured effect. And the plain population picture in the developed world runs the other way: the United States, with high circumcision rates, has higher HIV prevalence than the largely uncircumcised countries of western Europe. Condoms remain far more effective and do not require surgery on someone who cannot consent.

Urinary tract infection

Circumcision does lower the risk of UTI in the first year of life, by around tenfold in relative terms (Singh-Grewal 2005). But the baseline risk is about one percent, so in absolute terms you would need to circumcise roughly 100 boys to prevent one UTI, and that UTI is normally treated with a short course of antibiotics. Modern paediatric guidelines do not even recommend routine preventive antibiotics after a first UTI, let alone surgery.

Penile cancer

Penile cancer is rare in developed countries, fewer than one case per 100,000 men per year. Roughly a third to a half of cases are linked to HPV. Childhood circumcision shows a protective association in the main review (Larke 2011), but that signal weakens once you account for phimosis, which is itself treatable without surgery. Because the disease is so rare, the number of circumcisions needed to prevent a single case runs into the hundreds or thousands. The American Cancer Society does not recommend circumcision to prevent penile cancer. The modern, evidence-based prevention is the HPV vaccine, along with not smoking and ordinary hygiene.

HPV and other sexually transmitted infections

In the Ugandan trial data (Tobian 2009), adult circumcision reduced HPV prevalence in men by about a third and HSV-2 by about a quarter. It produced no significant reduction in syphilis. Here the comparison with alternatives is stark: the HPV vaccine is over 90 percent effective at preventing the HPV types it targets, far more than circumcision's roughly one-third, and it protects women directly too. These are things a person can choose later, for themselves.

Phimosis and balanitis

A foreskin that does not retract is normal in young boys and resolves on its own with age (Oster 1968). When phimosis or inflammation does need treatment, the first-line treatment is a topical steroid cream, which resolves most cases (Cochrane review, Moreno 2014 and 2024), or simple hygiene measures. Circumcision is a legitimate treatment for the small number of cases with real scarring (such as lichen sclerosus) or that do not respond to creams. That is surgery to treat an actual condition in a specific person, which is a world away from removing the foreskin of a healthy newborn.

The risks and harms

Every surgery has complications, and the honest difficulty here is that nobody knows the true rate. The AAP's own 2012 technical report admits "the true incidence of complications after newborn circumcision is not known." The figures that exist depend entirely on what was counted and for how long.

• Short-term complications such as bleeding and infection are reported at roughly 0.2 to 1.5 percent in hospital data (El Bcheraoui 2014; Weiss 2010), though definitions vary widely.
• Meatal stenosis, a narrowing of the urinary opening that can appear months or years later, is the clearest example of the reporting gap. Studies based on billing records put it under one percent, while studies that actually examined boys found it in 7 to 18 percent (Van Howe 2006; Acimi 2022). Records-based studies simply miss complications that show up later in a different clinic.
• Rare catastrophic injuries, including partial amputation of the glans, are documented in the surgical literature (Pippi Salle 2013).
• Death is rare. The best available estimate, from inpatient data, is on the order of one death per 49,000 circumcisions, and the authors note it is correlational and probably an undercount (Earp 2018). Much higher figures circulate online, but they rest on flawed methods and should not be trusted, in either direction.

On pain, the evidence is clear and one-sided: newborns feel it. They have working pain pathways (Anand and Hickey 1987) and mount a measurable stress response, with cortisol rising several-fold during the procedure. Available pain relief reduces but does not eliminate that response (Cochrane review, Brady-Fryer 2004), and the AAP states that adequate analgesia should always be provided. Boys circumcised as newborns show a stronger pain response to routine vaccination months later (Taddio 1997). What is not established, and what this page will not claim, is lasting psychological trauma; the studies alleging it are weak, and the most rigorous reviews find no reliable evidence for it. The defensible statement is simply that the acute pain is real and has measurable short-term effects.

The foreskin is functional tissue

Circumcision is often described as removing a small, spare flap of skin. Anatomically that is not accurate. The foreskin is a substantial double layer of tissue, on the order of 30 to 50 square centimetres in an adult (Kigozi 2009), with a specialised band of nerve-rich mucosa and a distinct inner surface (Taylor 1996; García-Mesa 2021). Whether its loss meaningfully reduces sexual sensation is genuinely debated in the literature, with careful studies on both sides, and this site does not overstate that. What is not in dispute is that healthy, functional tissue is being removed. The companion page, why the foreskin matters, covers the anatomy and the sensation debate in full.

The heart of it: consent

Strip away the back-and-forth over percentages and one fact does not move: infant circumcision permanently removes healthy, functional tissue from a person who cannot agree to it, for reasons that are not medically necessary. Every other argument is secondary to that.

This is the ground on which the ethics literature increasingly settles. A growing body of work in medical ethics argues that non-therapeutic genital cutting of a child conflicts with the child's right to bodily integrity and to an open future, the right to reach adulthood with his own body intact and make permanent decisions about it himself (Earp 2015; Earp 2016). A 2019 consensus article by an international group of ethicists and clinicians argued that all medically unnecessary childhood genital cutting should be held to a single standard of consent and bodily integrity (Brussels Collaboration 2019). The Dutch medical association put the practical version of it plainly: if there is any real benefit, it can wait until the boy can weigh it and decide, or choose a less drastic alternative, for himself.

None of this requires believing circumcision has zero benefit, or judging anyone who was circumcised or who made the decision with the information they had. It requires only the ordinary principle that we do not perform permanent, medically unnecessary surgery on people who cannot consent when the decision can simply wait for them.

The bottom line

• No national medical body recommends routine infant circumcision, and the one that came closest has let its statement expire.
• The benefits are real but modest in absolute terms in a developed country, and each one is achievable by a less invasive route: vaccination, condoms, hygiene, medicine, or the person's own later choice.
• The harms are permanent, under-counted, and include real pain, with a small but genuine rate of serious complications.
• The decisive point is consent. It is healthy tissue, a non-consenting child, and a decision that can wait.

If you want to talk about this with someone

The most persuasive approach is the calm, sourced one. You do not need to win an argument, and heat tends to lose the room. A few principles keep you on solid ground:

• Concede what is true. Yes, the African HIV trials found a real effect. Then move to what matters: absolute size, the developed-world context, and consent. Agreeing on the facts makes the rest credible.
• Lead with consent, not sensation. The autonomy argument does not depend on any contested study. The sexual-sensation question is real but unsettled, so do not stake your case on it.
• Cite, do not assert. "The AAP itself said the benefits are not enough to recommend it, and that statement has expired" lands harder than a strong adjective. The references below are here for exactly this.
• Keep it about the ethics and the evidence. This is a question of medical ethics and children's rights, applied the same way to every non-therapeutic infant circumcision whatever the reason. Keep it there.

References

Positions and figures above are drawn from the following. Links go to the source record where one is freely available.

1. American Academy of Pediatrics, Task Force on Circumcision. Circumcision Policy Statement. Pediatrics. 2012;130(3):585-586. PMID 22926180
2. AAP Task Force on Circumcision. Male Circumcision (Technical Report). Pediatrics. 2012;130(3):e756-e785. PMID 22926175
3. Frisch M, Aigrain Y, Barauskas V, et al. Cultural bias in the AAP's 2012 Technical Report and Policy Statement on male circumcision. Pediatrics. 2013;131(4):796-800. PMID 23509170
4. Sorokan ST, Finlay JC, Jefferies AL; Canadian Paediatric Society. Newborn male circumcision. Paediatr Child Health. 2015;20(6):311-320. PMID 26435672
5. Royal Australasian College of Physicians. Circumcision of Infant Males (Policy Statement), 2010, updated 2022. racp.edu.au
6. Royal Dutch Medical Association (KNMG). Non-therapeutic circumcision of male minors. Utrecht: KNMG; 2010. knmg.nl
7. Nordic Children's Ombudsmen and paediatric associations. Joint statement on the circumcision of boys. Oslo, 30 September 2013.
8. World Health Organization / UNAIDS. New data on male circumcision and HIV prevention: policy and programme implications. Montreux; 2007. who.int
9. Morris BJ, Wamai RG, Henebeng EB, et al. Estimation of country-specific and global prevalence of male circumcision. Popul Health Metr. 2016;14:4. PMC4772313
10. Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk (ANRS 1265). PLoS Med. 2005;2(11):e298. PMID 16231970
11. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369(9562):643-656. PMID 17321310
12. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657-666. PMID 17321311
13. Siegfried N, Muller M, Deeks JJ, Volmink J. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev. 2009;(2):CD003362. Cochrane
14. Millett GA, Flores SA, Marks G, et al. Circumcision status and risk of HIV and STIs among men who have sex with men: a meta-analysis. JAMA. 2008;300(14):1674-1684. PMID 18840841
15. Singh-Grewal D, Macdessi J, Craig J. Circumcision for the prevention of urinary tract infection in boys: a systematic review. Arch Dis Child. 2005;90(8):853-858. PMID 15890696
16. Larke NL, Thomas SL, dos Santos Silva I, Weiss HA. Male circumcision and penile cancer: a systematic review and meta-analysis. Cancer Causes Control. 2011;22(8):1097-1110. PMID 21695385
17. Olesen TB, Sand FL, Rasmussen CL, et al. Prevalence of HPV DNA and p16 in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis. Lancet Oncol. 2019;20(1):145-158. PMID 30573285
18. Tobian AAR, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med. 2009;360(13):1298-1309. PMID 19321868
19. Giuliano AR, Palefsky JM, Goldstone SE, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med. 2011;364(5):401-411. PMID 21288094
20. Oster J. Further fate of the foreskin: incidence of preputial adhesions, phimosis, and smegma among Danish schoolboys. Arch Dis Child. 1968;43(228):200-203. PMID 5689532
21. Moreno G, Corbalán J, Peñaloza B, Pantoja T. Topical corticosteroids for treating phimosis in boys. Cochrane Database Syst Rev. 2014;(9):CD008973. PMID 25180668
22. Weiss HA, Larke N, Halperin D, Schenker I. Complications of circumcision in male neonates, infants and children: a systematic review. BMC Urol. 2010;10:2. PMID 20158883
23. El Bcheraoui C, Zhang X, Cooper CS, et al. Rates of adverse events associated with male circumcision in US medical settings, 2001 to 2010. JAMA Pediatr. 2014;168(7):625-634. PMID 24820907
24. Van Howe RS. Incidence of meatal stenosis following neonatal circumcision in a primary care setting. Clin Pediatr (Phila). 2006;45(1):49-54. PMID 16429216
25. Acimi S, Abderrahmane N, Debbous L, et al. Prevalence and causes of meatal stenosis in circumcised boys. J Pediatr Urol. 2022;18(1):89.e1-89.e6. PMID 34740536
26. Pippi Salle JL, Jesus LE, Lorenzo AJ, et al. Glans amputation during routine neonatal circumcision. J Pediatr Urol. 2013;9(6 Pt A):763-768. PMID 23137994
27. Earp BD, Allareddy V, Allareddy V, Rotta AT. Factors associated with early deaths following neonatal male circumcision in the United States, 2001 to 2010. Clin Pediatr (Phila). 2018;57(13):1532-1540. DOI 10.1177/0009922818790060
28. Anand KJS, Hickey PR. Pain and its effects in the human neonate and fetus. N Engl J Med. 1987;317(21):1321-1329. PMID 3317037
29. Brady-Fryer B, Wiebe N, Lander JA. Pain relief for neonatal circumcision. Cochrane Database Syst Rev. 2004;(4):CD004217. PMID 15495086
30. Taddio A, Katz J, Ilersich AL, Koren G. Effect of neonatal circumcision on pain response during subsequent routine vaccination. Lancet. 1997;349(9052):599-603. PMID 9057731
31. Kigozi G, Wawer M, Ssettuba A, et al. Foreskin surface area and HIV acquisition in Rakai, Uganda. AIDS. 2009;23(16):2209-2213. PMID 19770623
32. Taylor JR, Lockwood AP, Taylor AJ. The prepuce: specialized mucosa of the penis and its loss to circumcision. Br J Urol. 1996;77(2):291-295. PMID 8800902
33. Earp BD. Female genital mutilation and male circumcision: toward an autonomy-based ethical framework. Medicolegal and Bioethics. 2015;5:89-104. DOI 10.2147/MB.S63709
34. Earp BD. In defence of genital autonomy for children. J Med Ethics. 2016;42(3):158-163. PMID 26792817
35. The Brussels Collaboration on Bodily Integrity. Medically unnecessary genital cutting and the rights of the child: moving toward consensus. Am J Bioeth. 2019;19(10):17-28. PMID 31557092
36. Council of Europe, Parliamentary Assembly. Resolution 1952 (2013), Children's right to physical integrity (adopted 1 October 2013); and the later Resolution 2076 (2015). assembly.coe.int
37. Læknafélag Íslands (Icelandic Medical Association). Submission (umsögn) to Alþingi on bill 114/148 to ban non-medical circumcision of boys. 8 March 2018. althingi.is
38. Lægeforeningen (Danish Medical Association). Position on circumcision of boys without a medical indication. 2016. laeger.dk
39. Sveriges läkarförbund (Swedish Medical Association), Council on Ethics and Responsibility. Position on circumcision of boys. slf.se
40. Suomen Lääkäriliitto (Finnish Medical Association). Lääkärin etiikka: Poikien ympärileikkaus (Medical ethics: circumcision of boys). 2021. laakariliitto.fi
41. Comité consultatif de Bioéthique de Belgique (Belgian Advisory Committee on Bioethics). Opinion No. 70 on the ethical aspects of non-medical circumcision. 8 May 2017. health.belgium.be
42. Deutscher Ethikrat (German Ethics Council). Recommendation on religious circumcision of male minors. 23 August 2012. ethikrat.org